Impact of Bacterial Phenotypic Variation with Bacteriophage therapy: A Pilot Study with Prosthetic Joint Infection Isolates.
JournalInternational Journal of Infectious Diseases : IJID
MetadataShow full item record
AbstractBackground: Given the specificity of bacteriophage attachment receptors, a single bacterial isolate is currently utilized to match to a bacteriophage therapeutic thereby extrapolating activity to all bacteria in vivo. Obstinately, the main bacteriophage attachment receptor for Staphylococcus aureus is teichoic acid and it is known that this receptor has phenotypic variations in different in vivo environments. Consequently, the aim of this study was to determine if bacteriophage activity is similar across all in vivo prosthetic joint infection environments. Methods: Three patients with prosthetic joint infections who had S. aureus grow from arthrocentesis cultures and at least three deep tissue cultures were analyzed for growth inhibition with a library of 56 bacteriophages RESULTS: Discordant bacteriophage activity was seen across the different in vivo environments. As well bacteriophages with the most robust lytic potential to the arthrocentesis isolates usually did not have activity to all the deep tissues clinical isolates. Conclusion: Variations of bacteriophage activity can occur between the different in vivo clinical environments which is likely secondary to different glycosylation patterns of teichoic acid. Consequently, if discordant activity is present then retreating with bacteriophages that have activity is likely needed for effective, reproducible outcomes.
Rights/TermsCopyright © 2022. Published by Elsevier Ltd.
KeywordAttachment receptors, Staphylococcus
Prosthetic joint infections
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/18508
- Assessment of Staphylococcal Clinical Isolates from Periprosthetic Joint Infections for Potential Bacteriophage Therapy.
- Authors: DePalma BJ, Nandi S, Chaudhry W, Lee M, Johnson AJ, Doub JB
- Issue date: 2022 Apr 20
- Successful Treatment of <i>Staphylococcus aureus</i> Prosthetic Joint Infection with Bacteriophage Therapy.
- Authors: Ramirez-Sanchez C, Gonzales F, Buckley M, Biswas B, Henry M, Deschenes MV, Horne B, Fackler J, Brownstein MJ, Schooley RT, Aslam S
- Issue date: 2021 Jun 21
- Human Plasma Significantly Reduces Bacteriophage Infectivity Against Staphylococcus aureus Clinical Isolates.
- Authors: Shinde P, Stamatos N, Doub JB
- Issue date: 2022 Apr
- Evaluation of Bacteriophage Anti-Biofilm Activity for Potential Control of Orthopedic Implant-Related Infections Caused by Staphylococcus aureus.
- Authors: Morris J, Kelly N, Elliott L, Grant A, Wilkinson M, Hazratwala K, McEwen P
- Issue date: 2019 Jan
- Bacteriophage therapy for bone and joint infections.
- Authors: Gibb BP, Hadjiargyrou M
- Issue date: 2021 Feb